Candida auris (C. auris) has hit every state in the nation. It is antimicrobial-resistant, which means it guards itself from antibiotics, antifungals, antivirals, antimalarials and anthelmintics, according to the Centers for Disease Control and Prevention (CDC). It changes to “dodge” the effectiveness of these drugs. This is why it can be deadly. (Here are dangerous conditions a simple blood test can help detect.)
[in-text-ad]
CDC epidemiologist Dr. Meghan Lyman, commented, “The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control.” It was first reported in 2016 and has spread aggressively since then.
[nativounit]
Cases are particularly prevalent in some of America’s largest states. According to the CDC, these include New York, California, Texas, Illinois and Florida. These states have about half the U.S. population. Health care aimed at COVID-19 may be among the reasons for the spread. The medical field may not have paid enough attention. The World Health Organization says containing Candida auris should be a goal in every country.
[wallst_email_signup]
The media recently has begun to report on Candida auris. USA Today recently reported, “Fungal infections can be life-threatening to those most at risk in hospital settings, including patients who are very sick, have invasive medical devices, or have long or frequent stays in health care facilities.” Put another way, people who are already vulnerable to infection because they are in medical settings are the most likely to be affected.
[recirclink id=1112347]
One question about Candida auris is whether the world is about to trade one massive infectious disease attack for another. COVID-19 has killed over a million Americans. It probably has infected over three-quarters of the U.S. population and has crushed parts of the economy that required a massive government effort to repair. Americans cannot imagine this could happen so fast, but, early on, they did not expect COVID-19 could do such devastating damage.
States Hit by Dangerous Fungus
© Dr_Microbe / iStock via Getty Images
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.
Top Gaining Stocks
Top Losing Stocks